All Stocks/Consumer Cyclical/SGI

SOMNIGROUP INTERNATIONAL INC.

SGI
Consumer CyclicalFurnishings, Fixtures & Appliances Website
Price ChartPowered by TradingView
Ask about SGIAI research agent
Alpha Score BreakdownHow it works →

Alpha Score of 53 reflects moderate overall profile with moderate momentum, moderate value, weak quality, moderate sentiment.

Momentum
65
Moderate
Value
50
Weak
Quality
44
Weak
Sentiment
50
Weak
Key StatisticsUpdated Apr 15
P/E Ratio
60.76
Forward P/E
–
PEG Ratio
–
EPS (TTM)
1.34
Dividend Yield
83.09%
Beta
1.35
Revenue (TTM)
–
Net Margin
5.14%
ROE
13.16%
Debt / Equity
1.51
52W High
$97.99
52W Low
$54.47
Top Institutional HoldersFrom 13F filings
FundShares HeldPosition ValueAction (latest Q)
Maverick Capital
Lee Ainslie
1.14M$101.94MNEW
Marshall Wace752K$67.12MNEW
Point72
Steve Cohen
409K$36.52MNEW
Soros Fund Management
George Soros (founder)
220K$19.64MNEW
Renaissance Technologies
Jim Simons (founder)
168K$15.03MNEW
Citadel
Ken Griffin
122K$10.90MNEW
D.E. Shaw
David Shaw
31K$2.73MNEW
Politicians who traded SGIFrom Senate & House PTRs
PoliticianDateTypeAmount
April McClain Delaney
D-MD
2026-08-25sale$100k – $250k
April McClain Delaney
D-MD
2026-07-30purchase$15k – $50k
April McClain Delaney
D-MD
2026-03-31purchase$1k – $15k
April McClain Delaney
D-MD
2026-03-16purchase$1k – $15k
Lisa McClain
R-MI
2025-10-30purchase$1k – $15k
About SOMNIGROUP INTERNATIONAL INC.

SomniGroup International Inc. is a key player in the global pharmaceutical and healthcare industry. Its primary function is to research, develop, and market innovative healthcare solutions aimed at improving health outcomes worldwide. SomniGroup is well-regarded for its development of life-saving medications and therapies focused on chronic and rare diseases, as well as its cutting-edge contributions to vaccine technology. The company has a diverse portfolio that includes over-the-counter pharmaceuticals, prescription drugs, and biotech products, serving a broad range of sectors from hospitals and clinics to retail pharmacies and healthcare providers. Headquartered strategically to leverage global supply chains, SomniGroup International Inc. plays a vital role in advancing medical science and enhancing public healthcare systems. By continually investing in R&D and forming strategic partnerships, the company remains at the forefront of delivering health innovations that meet both current and future needs of the medical industry.

CEO
Mr. Scott L. Thompson
Employees
19,000
Quick Facts
Exchange–
SectorConsumer Cyclical
IndustryFurnishings, Fixtures & Appliances
Market Cap–
Avg Volume3.46M
Key Dates

Earnings calendar coming soon. Subscribe to get notified when SGI reports next.

Get earnings alerts →